Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ezetimibe and Atorvastatin Calcium Tablets（Ⅱ）

Approval Number

国药准字H20253267

Company江苏诺泰澳赛诺生物制药股份有限公司

Registration Date

January 24, 2025

Drug Information

Generic Name

依折麦布阿托伐他汀钙片(Ⅱ)

Dosage Form

片剂

Strength

每片含依折麦布10mg与阿托伐他汀钙20mg（以阿托伐他汀计）

Drug Type

化学药品

Registration Date

January 24, 2025

Company Information

Applicant Company

Company Name江苏诺泰澳赛诺生物制药股份有限公司

Company Address

连云港经济技术开发区临浦路28号

Manufacturing Company

Company Name江西施美药业股份有限公司

Company Address

江西省抚州市东乡区大富工业园区

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy